The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
May 16, 1988
Going it alone may seem appealing, but it isn't always possible. Take BioPolymers, a Farmington, Conn., start-up that employs 18 scientists. Its three founders, marine biologist J. Herbert Waite, microbiologist Christine V. Benedict, and businessman Thomas M. Benedict, had an idea that venture capitalists couldn’t resist: to synthesize the potent protein that mussels use to cling to rocks. The sticky substance, would be invaluable for medical applications such as eye surgery where suture